Lobeline, a potential pharmacotherapy for drug addiction, binds to μ opioid receptors and diminishes the effects of opioid receptor agonists

Dennis K. Miller, John R. Lever, Kelli R. Rodvelt, James A. Baskett, Matthew J. Will, George R. Kracke

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Lobeline, a potential pharmacotherapy for drug addiction, binds to μ opioid receptors and diminishes the effects of opioid receptor agonists'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds